Practice Management
Drugmakers are developing new iterations of GLP-1 weight loss drugs that could result in fewer side effects. According to a news item in Becker’s Hospital Review, 27 GLP-1 drugs are in development, but the majority of the data is based on animal studies or early-stage human trials. In one example, researchers are optimistic about the experimental drug petrelinitide, which was shown to reduce body weight by an average of nearly 9% at 16 weeks. It …
Read More
Urgent message: With the epidemic of obesity and recent FDA-approval of weight loss drugs, urgent care providers should be on alert for patient presentations related to side effects of these agents. Introduction An estimated 154.7 million Americans over the age of 20 are currently overweight or obese. These Americans are at increased risk of disease, including diabetes mellitus, cardiovascular disease, end-stage renal disease and cancer. If current trends remain unchanged, an estimated $861 to $957 …
Read More